These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 33313060)

  • 41. Upstream and downstream regulators of Klotho expression in chronic kidney disease.
    Li SS; Sheng MJ; Sun ZY; Liang Y; Yu LX; Liu QF
    Metabolism; 2023 May; 142():155530. PubMed ID: 36868370
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of a single nucleotide polymorphism combination pattern of the Klotho gene with non-cardiovascular death in patients with chronic kidney disease.
    Cambray S; Bermudez-Lopez M; Bozic M; Valdivielso JM;
    Clin Kidney J; 2020 Dec; 13(6):1017-1024. PubMed ID: 33391745
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic deficiency of anti-aging gene klotho exacerbates early nephropathy in STZ-induced diabetes in male mice.
    Lin Y; Kuro-o M; Sun Z
    Endocrinology; 2013 Oct; 154(10):3855-63. PubMed ID: 23928372
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vascular calcification: When should we interfere in chronic kidney disease patients and how?
    Sharaf El Din UA; Salem MM; Abdulazim DO
    World J Nephrol; 2016 Sep; 5(5):398-417. PubMed ID: 27648404
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Investigation on urinary and serum alpha klotho in dogs with chronic kidney disease.
    Yi HJ; Lee JB; Lee KP; Oh YI; Song KH; Seo KW
    BMC Vet Res; 2020 Jul; 16(1):246. PubMed ID: 32677951
    [TBL] [Abstract][Full Text] [Related]  

  • 46. TGFβ-incurred epigenetic aberrations of miRNA and DNA methyltransferase suppress Klotho and potentiate renal fibrosis.
    Yin S; Zhang Q; Yang J; Lin W; Li Y; Chen F; Cao W
    Biochim Biophys Acta Mol Cell Res; 2017 Jul; 1864(7):1207-1216. PubMed ID: 28285987
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Uremic serum-induced calcification of human aortic smooth muscle cells is a regulated process involving Klotho and RUNX2.
    Patidar A; Singh DK; Thakur S; Farrington K; Baydoun AR
    Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31519772
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of Klotho in aging, phosphate metabolism, and CKD.
    John GB; Cheng CY; Kuro-o M
    Am J Kidney Dis; 2011 Jul; 58(1):127-34. PubMed ID: 21496980
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phosphate and Klotho.
    Kuro-O M
    Kidney Int Suppl; 2011 Apr; 79(121):S20-3. PubMed ID: 21346722
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early aging and premature vascular aging in chronic kidney disease.
    Tanriover C; Copur S; Mutlu A; Peltek IB; Galassi A; Ciceri P; Cozzolino M; Kanbay M
    Clin Kidney J; 2023 Nov; 16(11):1751-1765. PubMed ID: 37915901
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Klotho exerts protection in chronic kidney disease associated with regulating inflammatory response and lipid metabolism.
    Liu J; Wang H; Liu Q; Long S; Wu Y; Wang N; Lin W; Chen G; Lin M; Wen J
    Cell Biosci; 2024 Apr; 14(1):46. PubMed ID: 38584258
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Membrane-bound Klotho is not expressed endogenously in healthy or uraemic human vascular tissue.
    Mencke R; Harms G; Mirković K; Struik J; Van Ark J; Van Loon E; Verkaik M; De Borst MH; Zeebregts CJ; Hoenderop JG; Vervloet MG; Hillebrands JL;
    Cardiovasc Res; 2015 Nov; 108(2):220-31. PubMed ID: 26116633
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Klotho in health and disease.
    Kuro-o M
    Curr Opin Nephrol Hypertens; 2012 Jul; 21(4):362-8. PubMed ID: 22660551
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Secreted klotho and chronic kidney disease.
    Hu MC; Kuro-o M; Moe OW
    Adv Exp Med Biol; 2012; 728():126-57. PubMed ID: 22396167
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Vascular Calcification - Pathological Mechanism and Clinical Application - . Vascular calcification in chronic kidney disease-mineral and bone disorder (CKD-MBD)].
    Omata M; Fukagawa M; Kakuta T
    Clin Calcium; 2015 May; 25(5):645-53. PubMed ID: 25926567
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of exogenous growth hormone administration on circulating concentrations of α-klotho in healthy and chronic kidney disease subjects: a prospective, single-center open case-control pilot study.
    Adema AY; de Roij van Zuijdewijn CLM; Hoenderop JG; de Borst MH; Ter Wee PM; Heijboer AC; Vervloet MG;
    BMC Nephrol; 2018 Nov; 19(1):327. PubMed ID: 30442108
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Role of Disturbed Mg Homeostasis in Chronic Kidney Disease Comorbidities.
    Rodelo-Haad C; Pendón-Ruiz de Mier MV; Díaz-Tocados JM; Martin-Malo A; Santamaria R; Muñoz-Castañeda JR; Rodríguez M
    Front Cell Dev Biol; 2020; 8():543099. PubMed ID: 33282857
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characteristics of coronary artery disease in chronic kidney disease.
    Fujii H; Kono K; Nishi S
    Clin Exp Nephrol; 2019 Jun; 23(6):725-732. PubMed ID: 30830548
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Klotho: A Major Shareholder in Vascular Aging Enterprises.
    Lim K; Halim A; Lu TS; Ashworth A; Chong I
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31546756
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.